Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
06 sept. 2024 07h00 HE
|
https://immatics.com/
Houston, Texas and Tuebingen, Germany, September 06, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and...
Laverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule
05 sept. 2024 04h00 HE
|
Laverock Therapeutics
STEVENAGE, United Kingdom, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...
Cell Therapy Market Size to Hit USD 28.98 Billion by 2032, Driven by Advances in Personalized Medicine and Stem Cell Applications | SNS Insider
04 sept. 2024 09h00 HE
|
SNS Insider pvt ltd
Pune, Sept. 04, 2024 (GLOBE NEWSWIRE) -- “According to SNS Insider, The Cell Therapy Market, valued at USD 4.65 billion in 2023 and is projected to reach USD 28.98 billion by 2032, driven by a...
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024
03 sept. 2024 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Senti Bio to Participate in Upcoming Investor Conferences
03 sept. 2024 08h15 HE
|
Senti Biosciences, Inc.
Senti Bio will participate in two upcoming investor conferences in September.
CGT Research Outlook Technology Report 2024: Capacity and Capability Expansion for CDMOs, Technology Licensing Partnerships, Shift Towards CGT Development for Chronic Diseases
30 août 2024 06h46 HE
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "CGT Research Outlook and Technology Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The report covers the...
Researchers call for individualized gene therapies to be more widely accessible
29 août 2024 07h25 HE
|
MIT Sloan School of Management
Cambridge, MA, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Cambridge, MA, August 29, 2024 – As gene and cell therapy and gene editing technologies continue to revolutionize the treatment of genetic diseases,...
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
28 août 2024 08h34 HE
|
NurExone Biologic Inc
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Vor Bio to Participate in Upcoming Investor Conferences
28 août 2024 08h00 HE
|
Vor Biopharma
CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming...
KSQ Therapeutics to Participate in Upcoming Investor Conferences
28 août 2024 07h00 HE
|
KSQ
KSQ Therapeutics to Participate in Upcoming Investor Conferences